Notably, in that study, GPC4 levels were modestly elevated (~ 0.25-fold) in AD patients homozygous for APOE4, and remained unchanged in APOE3/3 and APOE2/2 patients compared to age-matched controls. The gene discussed is GPC4; the disease is Alzheimer disease.